Helicobacter Pylori and Acute Alcohol Induced Pancreatitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A recent pilot study unexpectedly discovered, that Helicobacter pylori infection was rare in patients having their first acute alcohol induced pancreatitis (AAIP) when compared to subjects with similar alcohol use but no history of pancreatitis. This subject has not been studied in humans until now. Therefore we seek to study, with a larger material, wether AAIP is associated with lower prevalence of Helicobacter pylori, by measuring the antibodies against Helicobacter pylori from the sera of AAIP patients and from a control group of alcoholics with no history of AAIP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatitis, Acute Helicobacter Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute alcohol pancreatitis (first)

Exclusion Criteria

* Death during hospitalization

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jahangir A Khan, MS

Role: PRINCIPAL_INVESTIGATOR

Department of Gastroenterology and Alimentary Tract Surgery, Tampere University

Isto Nordback, MD

Role: STUDY_DIRECTOR

1Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tampere University Hospital

Tampere, Pirkanmaa, Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

References

Explore related publications, articles, or registry entries linked to this study.

Pelli H, Herzig KH, Uotila S, Raty S, Laine S, Sand J, Nordback I. Duodenal diazepam-binding protein expression and plasma cholecystokinin after alcoholic pancreatitis. Scand J Clin Lab Invest. 2006;66(8):677-83. doi: 10.1080/00365510600930918.

Reference Type BACKGROUND

PMID: 17101560 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R00126-1

Identifier Type: -

Identifier Source: org_study_id